鲍曼不动杆菌atcc19606多重耐性分析及耐药基因的克隆
鲍曼不动杆菌ATCC19606多重耐性分析及耐药基因的克隆
鲍曼不动杆菌ATCC19606多重耐性分析及耐药基因的克隆
作者:苏显中 张兴 陈彦土 屋友房【摘要】 鲍曼不动杆菌已成为重
要的院内感染病菌。我们测定了鲍曼不动杆菌ATCC19606的药物最小
抑制浓度(MIC),结果显示该菌株对多种抗菌药物都有很高的耐性,
如链霉素、诺氟沙星、氯霉素、红霉素、四环素、氨苄西林及一些其
他的抗菌染剂。利用大肠埃希菌超敏菌株KAM32作为宿主,从鲍曼不
动杆菌ATCC19606染色体DNA中克隆耐药基因,共获得9个使宿主细
胞产生耐药性的杂合质粒,其中1个为单一耐药,其余全部为多重耐
药。根据药物特异性分析可知,具有不同耐药图谱的杂合质粒携带不
同类型的耐药基因。由此揭示鲍曼不动杆菌ATCC19606的多重耐药有
多种机制参与。 【关键词】 多重耐药; 基因克隆; 鲍曼不动杆菌
Multiple resistance in Acinetobacter baumannii ATCC 19606 and cloning of genes responsible for the resistance ABSTRACT Drug resistance of Acinetobacter baumannii ATCC 19606 was tested in this study. The result showed fairly high resistance to many antimicrobial agents tested including streptomycin, norfloxacin, chloramphenicol, erythromycin, tetracycline, ampicillin, and antimicrobial dyes. Using the drug
hypersensitive strain of Escherichia coli KAM32 as the host, we cloned the genes responsible for multiple resistance from chromosomal DNA of A.baumannii ATCC 19606. We obtained 9 hybrid plasmids that made host cells resistant to several antimicrobial agents. Many of the transformants harboring each of the plasmids showed multiple resistance, and one showed resistance to specific drug. The hybrid plasmids were classified into several groups based on their drug specificity. It appears that each class of plasmid carries different types of drug resistance genes. Analysis of such genes will reveal the various mechanisms involved in multiple resistance in A.baumannii ATCC 19606.
KEY WORDS Multiple resistance; Gene cloning; Acinetobacter baumannii
The appearance and spread of drug resistance in pathogenic organisms have made many available antibiotics ineffective,1, 2,. Drug resistance, especially multiple resistance, in bacterial cells has currently become an increasing serious clinical problem. An extensive knowledge of molecular mechanisms underlying bacterial drug resistance is required to control multiple resistant bacteria and to treat patients infected with multiple resistant bacteria successfully.
Certain strains of A.baumannii are now resistant to all commonly prescribed antibiotics (including imipenem and the new fluoroquinolones), and reports of a high prevalence of fluoroquinolone resistance among Acinetobacter isolates have appeared,3,4,.
It is important to investigate the mechanisms by which A.baumannii acquires drug resistance. In this study, we report patterns of drug resistance in strain A.baumannii ATCC 19606 and functional gene cloning of the drug resistance systems.
1 Materials and methods 1.1 Bacteria and growth
A.baumannii ATCC 19606 (generously provided by Professor Shigeo Yamamoto, Faculty of Pharmaceutical Sciences, Okayama University, Japan) and Escherichia.coli KAM32 were used in this study. E.coli TG1 and Pseudomonas aeruginosa PAO1 were also used. E.coli KAM32, a derivative of E.coli TG1, lacks the major multiple efflux pumps AcrB,5, and YdhE,6,, and shows
hypersensitivity to many antimicrobial agents and is useful as
a host for gene cloning of drug resistance systems. Bacterial
cells were grown in LB medium (Difco) with aeration at 37?
overnight. The growth of cells was monitored by measuring optical density at 650nm. 1.2 Drug susceptibility sest
The minimal inhibitory concentrations (MICs) of various drugs were determined by serial two fold dilution of
antimicrobials in the Mueller Hinton broth (Difco)
containing different drugs at various concentrations. MIC values were determined as a concentration of an antimicrobial that completely prevented cell growth during an 24h incubation at 37? with aeration. 1.3 Gene cloning
Chromosomal DNA was prepared from cells of A.baumannii ATCC 19606 by the method of Chen and Kuo,7,. The DNA was partially
digested with Sau3AI, and fragments of 4 to 10 kbp were separated by sucrose density gradient centrifugation. The DNA fragments were ligated into plasmid pBR322 (which was digested with BamHI and dephosphorylated with shrimp alkaline phosphatase) using a ligation kit, Ver. 2 (TaKaRa Co.). The ligated hybrid DNA was transformed into competent cells of E.coli KAM32, then the cells were spread onto agar (1.5%) plates containing LB broth, ampicillin100 μg/ml, and one of the
following drugs: norfloxacin (0.05 μg/ml), ethidium bromide
(10 μg/ml) or 4′, 6 diamidino 2 phenylindole (DAPI)
(0.5 μg/ml). The plates were incubated at 37? for 24 h. We
obtained 9 candidate colonies on the plates. Each candidate colony was purified by single colony isolation on the plate containing each drug. Plasmids were isolated from each of the candidates. Plasmid DNAs were retransformed in the KAM32 cells, spread on the same type of plate, and their resistance against
various antimicrobial agents tested. We confirmed that one type of plasmid was harbored in each candidate clone by the retransformation and by checking the restriction fragment of each plasmid. All hybrid plasmids carried DNA inserts of 3.0 to 11 kbp.